The study showed that DDX41 mutations are strongly linked to MDS prevalence (OR 1.57, 95% CI 1.30–1.91, I2 = 0%, P < 0.00001), whereas no statistically significant correlation between DDX41 gene mutation and AML prevalence. Here, DDX41 is linked to acute myeloid leukemia.